Intabio
Latest round
- Series B
Last raised
- Feb 2020
Total raised
- $30M
Investors
- 4
About Intabio
Intabio, Inc.Founded in 2015 and headquartered in Newark, US, Intabio, Inc. specializes in advanced mass spectrometry solutions. The founder's history is not documented, and there have been no reported pivots or subsidiaries.Intabio, Inc. focuses on iCIEF-MS Technology providing advanced mass spectrometry solutions for precise molecular detection and quantitation. Their product lineup includes innovative LC-MS systems, tailored consumables, and standards that support sample analysis in pharmaceuticals, clinical diagnostics, environmental monitoring, and food safety.Intabio, Inc. generates revenue through direct sales and partnerships, engaging in B2B transactions for mass spectrometry systems and consumables. Customized solutions and training programs complement their revenue model, with pricing reflecting the advanced capabilities of their flagship products.Following the acquisition by AB Sciex LLC, Intabio, Inc. aims to innovate its product offerings and expand its market reach. The company is focused on developing new products tailored to enhance research and diagnostics capabilities, with specific plans for geographic expansion into Asia and Europe by early 2023.
Who invested in Intabio
4 investors across 3 rounds
See all investors in Intabio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Intabio
Who invested in Intabio?
Intabio has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Intabio raised?
Intabio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Intabio last raise money?
Intabio's most recent round on record is a Series B, in Feb 2020.
What does Intabio do?
Intabio is a biotechnology company.
Where is Intabio headquartered?
Intabio is headquartered in Newark, US.
Which VCs invest in companies like Intabio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Intabio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Intabio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.